The future of Croatia's Institute of Immunology, which made and exported various vaccines to the developing world, has been questioned by a series of recent events.
The institute lost two licences from the national drug regulator last summer to make bacterial vaccines and plasma products due to inadequate safety infrastructure, and it is unclear if it will be able to keep its licence to make viral vaccines past 2015, according to local media reports.
The institute has since declared bankruptcy, given that most of its revenues were tied to it having the licences to manufacture and sell those products. But this was later annulled by a court and it is now undergoing restructuring and searching for private investors to allow it to restart some production. It has changed three directors in the last couple of months.
The institute's downfall has been widely seen as a consequence of neglect by its majority shareholder, the Croatian government, and the government's failure to invest in new technologies and infrastructure.
Read the rest of the article here.